Reed Smith LLP

GCR Live Pharmaceuticals

Inicio Eventos GCR Live Pharmaceuticals
The scrutiny of pricing in the pharmaceuticals sector has, if anything, become fiercer in 2018. How has this enforcement by the agencies and court decisions from private litigation affected the industry and its business practices?

Oradores:: Edward B. Schwartz

Tipo de evento: Seminario

Nombre de la ubicación:
2112 Pennsylvania Avenue, NW, Washington D.C. 20037
Fecha/hora de inicio:
28 February 2019, 10:15 AM ET
Fecha/hora de finalización:
28 February 2019, 11:30 AM ET

Please visit GCR Live to read more.

You May Be Interested

U.S. antitrust developments: Spotlight on new merger guidelines (Part 2)
Dealmaker Insights
24 April 2024
Replacement of CBER by SBER? What lies ahead for the liner shipping industry
Reed Smith In-depth
8 April 2024
U.S. antitrust developments: Antitrust enforcers take aim at private equity (Part 1)
Dealmaker Insights
3 April 2024
FTC and DOJ confirm “same rules apply” in second statement of interest regarding algorithmic price-fixing claims
1 April 2024